US Stock MarketDetailed Quotes

AFJK Aimei Health Technology

Watchlist
  • 10.400
  • +0.020+0.19%
Close Jul 26 16:00 ET
93.87MMarket Cap0.00P/E (TTM)

Aimei Health Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
--413.75K
--580.72K
--580.72K
--10K
-Cash and cash equivalents
--413.75K
--580.72K
--580.72K
--10K
Receivables
--302
----
----
----
-Related party accounts receivable
--302
----
----
----
Prepaid assets
--66.67K
----
----
----
Total current assets
--480.72K
--580.72K
--580.72K
--10K
Non current assets
Related parties assets
--302
----
----
----
Non current deferred assets
----
----
----
--224.95K
Other non current assets
--70.8M
--69.89M
--69.89M
----
Total non current assets
--70.8M
--69.89M
--69.89M
--224.95K
Total assets
--71.28M
--70.47M
--70.47M
--234.95K
Liabilities
Current liabilities
Current accrued expenses
--78.47K
--24.84K
--24.84K
--3.42K
Current debt and capital lease obligation
----
----
----
--210.15K
-Current debt
----
----
----
--210.15K
Current liabilities
--78.47K
--24.84K
--24.84K
--213.57K
Non current liabilities
Non current deferred liabilities
--690K
--690K
--690K
----
Total non current liabilities
--690K
--690K
--690K
--0
Total liabilities
--768.47K
--714.84K
--714.84K
--213.57K
Shareholders'equity
Share capital
--70.8M
--69.89M
--69.89M
--144
-common stock
--70.8M
--69.89M
--69.89M
--144
Retained earnings
---287.97K
---134.34K
---134.34K
---3.62K
Paid-in capital
----
--0
--0
--24.86K
Total stockholders'equity
--70.51M
--69.76M
--69.76M
--21.38K
Total equity
--70.51M
--69.76M
--69.76M
--21.38K
Currency Unit
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023
Assets
Current assets
Cash, cash equivalents and short term investments --413.75K--580.72K--580.72K--10K
-Cash and cash equivalents --413.75K--580.72K--580.72K--10K
Receivables --302------------
-Related party accounts receivable --302------------
Prepaid assets --66.67K------------
Total current assets --480.72K--580.72K--580.72K--10K
Non current assets
Related parties assets --302------------
Non current deferred assets --------------224.95K
Other non current assets --70.8M--69.89M--69.89M----
Total non current assets --70.8M--69.89M--69.89M--224.95K
Total assets --71.28M--70.47M--70.47M--234.95K
Liabilities
Current liabilities
Current accrued expenses --78.47K--24.84K--24.84K--3.42K
Current debt and capital lease obligation --------------210.15K
-Current debt --------------210.15K
Current liabilities --78.47K--24.84K--24.84K--213.57K
Non current liabilities
Non current deferred liabilities --690K--690K--690K----
Total non current liabilities --690K--690K--690K--0
Total liabilities --768.47K--714.84K--714.84K--213.57K
Shareholders'equity
Share capital --70.8M--69.89M--69.89M--144
-common stock --70.8M--69.89M--69.89M--144
Retained earnings ---287.97K---134.34K---134.34K---3.62K
Paid-in capital ------0--0--24.86K
Total stockholders'equity --70.51M--69.76M--69.76M--21.38K
Total equity --70.51M--69.76M--69.76M--21.38K
Currency Unit USDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg